Scott Buzby is an Online Content Editor at Healio. He specializes in medicine and healthcare, covering a range of topics including health news, consumer health, surgery, endocrinology, and alternative medicine. Scott's insights and expertise have been featured in various publications, showcasing his commitment to advancing knowledge in the health and wellness sectors.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Scott's articles focus heavily on scientific and healthcare topics, particularly cardiology and cardiovascular disease. Given his heavy reliance on data and press releases, he would likely be most responsive to pitches from researchers, medical professionals or industry experts who can provide factual insights backed by research findings or newsworthy data.
Potential outreach could include offering exclusive access to newly released studies, providing expert commentary on the implications of emerging medical research in the field of cardiology and related areas, as well as highlighting innovative approaches to healthcare that align with Scott’s coverage themes.
As Scott does not have a specific geographic focus but covers international health-related news stories extensively, sources from anywhere in the world may find relevance in reaching out for potential collaboration.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Scott Buzby
In patients with peripheral artery disease undergoing revascularization, major adverse limb events were more common with radial access compared with femoral access, driven by target vessel revascularization, a speaker reported. However, radial access was associated with shorter hospital stays and less use of contrast, the researchers found.
By: Richard Smith, Scott Buzby
Sacubitril/valsartan improved exercise hemodynamics, oxygen uptake and symptom burden in patients with heart failure with preserved ejection fraction and atrial functional mitral regurgitation, researchers reported.
Carotid atherosclerosis was a common finding among patients with atrial fibrillation who experienced breakthrough stroke, regardless of anticoagulant use, researchers reported.
By: Scott Buzby
Patients with obesity who underwent transcatheter aortic valve replacement experienced lower risk for heart failure and acute kidney injury at 1 year if they took tirzepatide than if they did not, researchers reported.Data suggest tirzepatide (Mounjaro/Zepbound, Eli Lilly) may improve cardiorenal health in this high-risk population, according to results presented at the Society for Cardiovascular
By: Richard Smith, Scott Buzby
Digitalis glycosides may be a safe and tolerable addition to optimal guideline medical therapy to reduce worsening heart failure events in patients with HF with mildly reduced or reduced ejection fraction, researchers reported.
Key takeaways: Lp(a) is a highly atherogenic particle with no available targeted therapeutics.
By: Scott Buzby, Richard Smith
Measures of ideal heart health including healthy levels of physical activity, BMI, BP and sleep were associated with lower risk for severe COVID-19
By: Scott Buzby, Richard Smith
A low-calorie diet and behavioral support program conferred weight loss in older participants with obesity and persistent atrial fibrillation but did not significantly improve AF symptoms vs. usual care, researchers reported.
By: Scott Buzby, Richard Smith
Genetic PCSK9 inhibition via base editing appeared safe and demonstrated dose-dependent, durable reductions in PCSK9 and LDL cholesterol, researchers reported.
By: Scott Buzby, Richard Smith
A wrist-worn device automatically detected induced cardiac arrest with a high degree of accuracy among patients undergoing subcutaneous implantable
